MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
54.42
-0.46 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
54.39
-0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
MoonLake Immunotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -56.05M | -40.56M | -46.4M | -36.91M | -24.27M | -13.67M | -7.44M | -11.62M | -12.35M | -12.22M | -16.47M | -14.74M | -17.42M | -15.88M | -2.22M | -6.29M | -32.69M | -76.29K |
Depreciation & Amortization | 742K | 378K | 1.3M | 32.52K | 28.11K | 22.81K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 2.49K | 3.48K | 2.27K | n/a | n/a |
Stock-Based Compensation | 3.31M | 2.29M | 1.93M | 1.84M | 1.83M | 1.68M | 1.61M | 1.43M | 1.5M | 2.58M | 2.6M | 2.59M | 2.48M | 1.99M | 7.76M | 1.86M | 1.25M | n/a |
Other Working Capital | n/a | -223K | -3.46M | 9.01M | -5.14M | -2.41M | -6.2M | 1.11M | -1.02M | 729.86K | 1.74M | 2.75M | -5.92M | 1.92M | 51.13K | 2.1M | n/a | -13.69K |
Other Non-Cash Items | -2.53M | 120K | -1.41M | 1.59M | 1.91M | 2.03M | -16.07K | -46.99K | -33.28K | 45.53K | 150.3K | 49.89K | 90.33K | 81.96K | -2.25K | 155.63K | 31.44M | -17.82K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 37.47K | -23.96K | -13.51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -369K | -3.9M | 8.17M | -5.32M | -2.84M | -6.54M | 1.01M | -1.26M | 568.55K | 2.12M | 2.75M | -5.92M | -379.14K | 1.86M | 2.26M | n/a | -13.69K |
Operating Cash Flow | -54.53M | -38.14M | -48.47M | -25.27M | -27.89M | -14.95M | -12.34M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -20.76M | -14.19M | -361.96K | -2.02M | 6.14K | -107.8K |
Capital Expenditures | n/a | -35K | -175.57K | -132.19K | 3.00 | -211.76K | -284.63K | n/a | n/a | n/a | n/a | n/a | -16.01K | -16.01K | -28.52K | -11.65K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -117.66M | -88.55M | -146.94M | -29.18M | -86.44M | -87.71M | -175.56B | -175.73M | n/a | n/a | n/a | -42.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 205.91M | 144.83M | -211.05K | 87.59M | -1.3M | 59.12M | 117.15M | 1.36M | 12.68M | 19.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 3.00 | -87.74M | -28.59M | 175.56B | -174.38K | 12.68K | 19.65K | 9.9M | -42.23K | 16.01K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 88.25M | 56.25M | -147.33M | 58.28M | -87.74M | -28.8M | 116.87M | -174.38M | 12.68M | 19.65M | 9.9M | -42.23M | 2.00 | -16.01K | -28.52K | -11.65K | n/a | n/a |
Debt Repayment | n/a | 73.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.44K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 52.69M | 91.8K | n/a | -1.56M | -2.75M | n/a | n/a | n/a | 3.79K | n/a | 104.69M | 3.79K | -548.95K | 3.28K | n/a | -58.06K |
Financial Cash Flow | n/a | 73.12M | 150.71K | 183.1K | n/a | 50.98M | 28.42M | n/a | 451.29M | n/a | 3.79K | n/a | 104.69M | 15M | 23.65M | 498.33K | n/a | -58.06K |
Net Cash Flow | 35.12M | 91.14M | -195.23M | 32.87M | -115.65M | 7.27M | 133M | -183.62M | 451.66M | 10.62M | -1.7M | -51.5M | 83.87M | 795.31K | -361.96K | -1.53M | 6.14K | -165.86K |
Free Cash Flow | -54.53M | -38.17M | -48.65M | -25.41M | -27.89M | -15.16M | -12.63M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -20.78M | -14.2M | -390.48K | -2.03M | 6.14K | -107.8K |